Our Mission
Ovation is a genomic data company committed to unlocking the potential of human genomic data at scale and accelerating precision medicine development.
By providing access to high-quality genomic data linked to rich, longitudinal phenotypic data at scale, Ovation allows life sciences researchers to advance drug discovery and development more efficiently. Ovation’s cloud-based LIMS and Ovation Research Network, enable a diverse network of clinical laboratories to quickly adopt innovative molecular tests while biobanking and transforming remnant samples to be used for research.
Our Leadership Team
Our leadership team is comprised of industry veterans who have a wealth of experience across life sciences, healthcare data, scientific research, technology, and clinical diagnostics industries.
Curt Medeiros
Chief Executive Officer
Winston Brasor
Co-Founder and GM LIMS
Barry Wark, PhD
Co-Founder & Chief Strategy Officer
Ed Stepanski, PhD
General Manager, Data
Pauline Gee, PhD
Vice President, Clinical Affairs
Zane Schafer
Chief Technology Officer
Chris Hargarten
Sr. Director Product Management, Data
Martin Miller
Chief Revenue Officer
Su Shen
Sr. Director Product Management, LIMS
Our Investors
